Hongkong WinHealth Pharma Group CO., Ltd and Immedica Pharma AB, today announce that they have entered an agreement under which WinHealth gains the exclusive commercial rights to Ravicti® (glycerol phenylbutyrate), in a territory covering the ...
As the novel coronavirus epidemic continues to evolve in China, the country has introduced controls to prevent the spread of the epidemic and reduce the risk of contagion.